共 1245 条
[1]
Zhu N(2020)A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med 382 727-733
[2]
Zhang D(2020)SARS-CoV-2 vaccines in development Nature 586 516-527
[3]
Wang W(2020)Postapproval vaccine safety surveillance for COVID-19 vaccines in the US JAMA 324 1937-1938
[4]
Li X(2021)Safety of COVID-19 vaccines administered in the EU: should we be concerned? Toxicol Rep 8 871-879
[5]
Yang B(2011)The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 d5928-926
[6]
Song J(2008)GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 924-13
[7]
Zhao X(2017)The GRADE Working Group clarifies the construct of certainty of evidence J Clin Epidemiol 87 4-1854
[8]
Huang B(2020)Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial Lancet 395 1845-488
[9]
Shi W(2020)Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial Lancet 396 479-413
[10]
Lu R(1934)The use of confidence or fiducial limits illustrated in the case of the binomial Biometrika 26 404-872